Organigram Global (OGI) Research & Development (2018 - 2026)
Organigram Global (OGI) posted quarterly Research & Development of $3.0 million for Q1 2026, up 61.51% year-over-year from $1.9 million in Q1 2025, and up 100.5% quarter-over-quarter from $1.5 million in Q4 2025.
Organigram Global (OGI) Research & Development (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Research & Development for 7 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 61.51% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $8.0 million (down 62.22% YoY), while the FY2025 annual figure was $7.7 million, changed N/A from the prior year.
- Research & Development climbed to $3.0 million in Q1 2026 per OGI's latest filing, from $1.5 million in the prior quarter.
- Across five years, Research & Development topped out at $3.0 million in Q1 2026 and bottomed at $1.5 million in Q4 2025.
- Historically, Research & Development has averaged $2.0 million across 3 years, with a median of $1.8 million in 2024.
- Annual changes were most pronounced in 2025 — Research & Development decreased 11.88% — and 2026, when it jumped 61.51%.
- Organigram Global's Research & Development stood at $1.7 million in 2024, then dropped by 11.88% to $1.5 million in 2025, then surged by 100.5% to $3.0 million in 2026.
- Business Quant data shows OGI's Research & Development at $3.0 million in Q1 2026, $1.5 million in Q4 2025, and $1.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Organigram Global | 152.05 Mn | 151.93 Mn | 28.97 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.70 Mn |
| May 31, 2021 | 10.92 Mn |
| Feb 28, 2021 | 6.81 Mn |
| Nov 30, 2020 | 646,000.00 |
| May 31, 2020 | 3.07 Mn |
| Feb 29, 2020 | 5.48 Mn |
| May 31, 2019 | 3.32 Mn |
| Feb 28, 2019 | 3.14 Mn |
| Nov 30, 2018 | 2.36 Mn |
| Aug 31, 2018 | 2.09 Mn |
| May 31, 2018 | 1.49 Mn |